1. Baron, J.C., Samson, Y., Crouzel, C. et al. 1985b. Pharmacologic studies in man with PET: an investigation using l-labeled ketanserin, a 5-HT2 receptor antagonist. In “Cerebral Blood Flow and Metabolism Measurement”. (Eds. A. Hartmann, S. Hoyer). (Springer, Berlin, Heidelberg, New York), pp. 473–480.
2. Baron, J.C., Comar, D., Zarifian, E. et al. 1985a. Dopaminergic receptor sites in human brain: positron emission tomography. Neurology, 35, 1624.
3. Bokobza, B., Ruberg, M., Scatton, B. et al. 1984. 3H-spiperone binding, dopamine and HVA concentrations in Parkinson’s disease and supranuclear palsy. Eur. J. Pharmacol., 99, 167–175.
4. Crawley, J.C.W., Smith, T., Yeall, N. et al. 1983. Dopamine receptors displayed in human living brain with 77Br-p-bromospiperone. Lancet, II, 975.
5. Farde, L., Ehrin, E., Eriksson, L. et al. 1985. l-labeled dopamine-2-receptor antagonists as tools for quantitative studies or dopamine receptors in the human brain. In “Brain 85”, 16–20 June 1985, Ronneby, Sweden, pp. 205.